Biktarvy 50-200-25 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FK883
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $62,258
Award facts
- Contract value 100% obligated
- $62,258.02 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded Amerisourcebergen Drug Corp a delivery order valued at $62,258.02 on January 8, 2026, for the supply of BIKTARVY 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award status. The contract will be performed at the awardee's location in Conshohocken, Pennsylvania, with an ultimate completion date of January 9, 2026. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc. (doing business as Amerisourcebergen), a major pharmaceutical distributor that serves as a critical vendor for federal medical procurement.
This delivery order is issued under Amerisourcebergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including medications, vaccines, and specialized medical commodities across multiple therapeutic domains. The parent company, Cencora, Inc., holds a separate IDC with the DLA valued up to $999,999,999.00 through December 31, 2031, further demonstrating the company's significant role in supporting Department of Defense healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FK883?
SPE2DR26FK883 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 8, 2026.
How much is contract SPE2DR26FK883 worth?
The government has obligated $62,258 on SPE2DR26FK883.
Is contract SPE2DR26FK883 an order under another contract?
Yes. SPE2DR26FK883 is a delivery order under SPE2DR25D1104, an indefinite delivery contract.
Was contract SPE2DR26FK883 competed?
The extent of competition for SPE2DR26FK883 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award